Hematologic Malignancy
Pediatric and/or Germline Mutation-Associated Myeloid Disorders
CI-CAN-00001395Explore in graph →
PediatricHematologicNon-malignant16 active trials1 approved drugs1 evidence items
- NCIt
- C198663
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001395Explore in graph →
Clinical trials
63 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02061800 | CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant | unknown | Phase 1 / Phase 2 | 14 | Diane GeorgeOTHER | 1 | Jun 4, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jun 4, 2024source: clinicaltrials